Elevance Health
- Market cap
- 89.12B
- P/E (TTM)i
- 18.18
- P/Bi
- 1.99
- EPSi
- 25.21
- Div yieldi
- 1.67%
- 52W posi
- 86%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Elevance Health closed at 410.95, down 0.80%. The company carries a market value of roughly 89.12B, the #184 most valuable US-listed company we track. Valuation-wise, the P/E sits at 18.11, broadly in line with the five-year average of 17.22. It pays a dividend yielding 1.67% on a trailing basis. Across 17 analysts the consensus rating is Buy, with an average price target of 450.27 (+10%). Over the past year the stock has ranged from 270.87 to 434.35; it now sits 86% up that band.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 months.
- Recent price momentum is +19.5% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 2.5% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 299 U.S. stocks StockVane covers.
Valuation A-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 18.2x | Better than 66% |
| Forward P/E | 16.6x | Better than 64% |
| Price / Sales | 0.4x | Better than 98% |
| P/E vs own 5-yr range | 58th pctl | Better than 55% |
Growth C-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 8.3% | Better than 54% |
| Net income CAGR (3Y) | -1.3% | Better than 30% |
| Free cash flow CAGR (3Y) | -24.1% | Better than 11% |
Profitability D+
How much profit the business keeps from each dollar of sales and capital.
| Net margin | 2.8% | Better than 8% |
| Return on equity | 13.3% | Better than 36% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 6.2% | Better than 62% |
| 6-month return | 42.2% | Better than 88% |
| 12-month return (ex latest month) | 29.7% | Better than 55% |
| Distance below 52-week high | 5.4% | Better than 83% |
Financial Health C
Balance-sheet strength: leverage, liquidity and interest coverage.
| Debt to assets | 26.4% | Better than 71% |
| Interest coverage | 5.8x | Better than 30% |
| Free cash flow / net income | 56.1% | Better than 17% |
Analyst View C-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 64.7% | Better than 34% |
| Upside to average target | 9.6% | Better than 19% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 414.26
- Open
- 414.68
- Day range
- 406.38 - 415.36
- Avg price
- 410.66
- Volume
- 2.08M
- Turnover
- 852.66M
- Turnover ratei
- 0.96%
- Volume ratioi
- 1.66
- Amplitudei
- 2.17%
- 52-week rangei
- 270.87 - 434.35
Valuation
- P/Ei
- 16.30
- P/E (TTM)i
- 18.18
- P/Bi
- 1.99
- EPSi
- 25.21
- Book value / shi
- 206.96
- Net profit
- 5.47B
- Net assets
- 44.88B
Share structure
- Market cap
- 89.12B
- Float capi
- 88.92B
- Shares out
- 216.87M
- Float sharesi
- 216.37M
Dividend & listing
- Div yield (TTM)i
- 1.67%
- Dividend (TTM)
- 6.86
- Listing date
- 1970-01-01
5.4% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-14.77M net over the window
Short interest
- Shares short
- 5.49M
- % of floati
- 2.53%
- Days to coveri
- 6.56
- As of
- 2026-08-31
Frequently asked questions
What is the current stock price of Elevance Health (ELV)?
Elevance Health last traded at 410.95. The quote on this page refreshes every few seconds while US markets are open.
What is Elevance Health's market cap?
About 89.12B.
What is the P/E ratio of Elevance Health?
The trailing twelve-month P/E is 18.18, above its own 5-year average of 17.22 — in the middle of its historical range (57.82% percentile). See the Valuation tab for the full history.
Does Elevance Health pay a dividend?
Yes. The trailing dividend yield is 1.67%. See the Dividends tab for the full payment history.
Is Elevance Health a buy according to analysts?
The consensus of 17 analysts is a Buy rating, with an average 12-month price target of 450.27, which implies 9.6% upside from the current price. This is not investment advice.
Quote time 2026-09-18 19:30:06 · For reference only, not investment advice.